Viewing Study NCT03158792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-02-20 @ 3:42 PM
Study NCT ID: NCT03158792
Status: COMPLETED
Last Update Posted: 2017-09-11
First Post: 2017-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
Sponsor: Lebanese American University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolism View
None Renal Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anticoagulation View
None Thromboprophylaxis View
None Anti-Xa levels View
None Elderly View
None Prevention View
None Enoxaparin View
None Low molecular weight heparin View